...
首页> 外文期刊>Artificial Organs >Hemodiafiltration With Online Regeneration of Ultrafiltrate: Effect on Heme-Oxygenase-1 and Inducible Subunit of Nitric Oxide Synthase and Implication for Oxidative Stress and Inflammation
【24h】

Hemodiafiltration With Online Regeneration of Ultrafiltrate: Effect on Heme-Oxygenase-1 and Inducible Subunit of Nitric Oxide Synthase and Implication for Oxidative Stress and Inflammation

机译:血液透析滤过与超滤液的在线再生:对血红素氧化酶-1和一氧化氮合酶的诱导亚基的影响以及对氧化应激和炎症的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Hemodiafiltration with regeneration of ultrafiltrate (HFR) has a positive impact on inflammation and oxidative stress (OxSt), risk factors for cardiovascular disease (CVD), the most common cause of excess morbidity and mortality for end-stage renal disease (ESRD) patients. However, studies have been of limited duration. This study extends our previous study of HFR effects by evaluating the effect on mononuclear cell protein expression of heme-oxygenase-1 (HO-1), induced by OxSt, and inducible subunit of nitric oxide synthase (iNOS), and plasma level of interleukin-1β (Il-1β) and oxidized low-density lipoproteins (OxLDL), marker of OxSt, for a 12-month period. Fourteen ESRD patients stable on hemodialysis over a period of at least 2 years and on conventional bicarbonate dialysis were switched to be treated with HFR. Blood samples were collected at baseline, after 3, 6, 9 and 12 months. HO-1 and iNOS protein expression were evaluated by Western blot, OxLDL by enzyme-linked immunosorbent assay (ELISA), and Il-1β by enzyme amplified sensitivity immumoassay assay. HFR significantly increased HO-1 at the 9 and 12 months (ANOVA?=?P?
机译:血液透析滤过与超滤液的再生(HFR)对炎症和氧化应激(OxSt),心血管疾病(CVD)的危险因素具有积极影响,而心血管疾病是终末期肾脏疾病(ESRD)患者过度发病率和死亡率的最常见原因。但是,研究持续时间有限。这项研究通过评估对OxSt诱导的血红素加氧酶-1(HO-1)单核细胞蛋白表达和一氧化氮合酶(iNOS)的诱导亚基的影响以及血浆白介素水平,扩展了我们先前对HFR的研究。 -1β(Il-1β)和氧化的低密度脂蛋白(OxLDL)(OxSt的标志物)持续12个月。十四名在血液透析中稳定了至少2年并且在常规碳酸氢盐透析中稳定的ESRD患者被改用HFR治疗。 3、6、9和12个月后在基线时采集血液样本。通过蛋白质印迹法评估HO-1和iNOS蛋白的表达,通过酶联免疫吸附测定(ELISA)评估OxLDL,通过酶扩增敏感性免疫测定法评估Il-1β。 HFR在9和12个月时显着增加HO-1(ANOVA?=?P?<?0.00001):0.17?±?0.11(基线)与0.48?±?0.20,P?<?0.043和0.59?±?0.32 ,P≤0.004。自三个月以来,Il-1β下降(ANOVA?=?P?<?0.0001)从169.92?±?92.39?pg / mL(基线)降至39.03?±?10.01(12个月),P?<?0.0001。 HFR还使血浆OxLDL降低:475.4±±110.8ng / mL(基线),而393.1±±101.9μng/ mL(12个月),P << 0.04。 iNOS在HFR治疗后未显示任何变化。这些结果以及我们以前的结果表明,HFR可以改善OxSt和炎症。鉴于OxSt与CVD炎症之间的密切关系,通过降低透析患者的动脉粥样硬化CVD风险,减少它们可能会产生有益的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号